CHCCX | VMGIX | CHCCX / VMGIX | |
Total Expense Ratio | 1.71 | 0.19 | 900% |
Annual Report Gross Expense Ratio | 1.71 | 0.19 | 900% |
Fund Existence | 32 years | 19 years | - |
Gain YTD | 0.733 | 12.372 | 6% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.58B | 32.4B | 8% |
Annual Yield % from dividends | 0.00 | 0.51 | - |
Returns for 1 year | 6.46 | 22.81 | 28% |
Returns for 3 years | 16.71 | 37.41 | 45% |
Returns for 5 years | -39.94 | 59.92 | -67% |
Returns for 10 years | -38.96 | 167.01 | -23% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFSC | 27.27 | 0.19 | +0.72% |
F/m Emerald Life Sciences Innovation ETF | |||
QTAP | 43.08 | N/A | N/A |
Innovator Growth-100 Acltd Ps ETF™ April | |||
OCIO | 36.28 | -0.04 | -0.12% |
ClearShares OCIO ETF | |||
GCOR | 41.22 | -0.07 | -0.17% |
Goldman Sachs Access US Aggregate Bd ETF | |||
AVLV | 70.60 | -0.23 | -0.32% |
Avantis US Large Cap Value ETF |